key: cord-0729338-owep0vsp authors: Kabir, Tousif; Kam, Juinn Huar; Chew, Min-Hoe title: Cholecystectomy during the COVID-19 pandemic: current evidence and an understanding of the ‘new’ critical view of safety: Correspondence date: 2020-06-09 journal: Int J Surg DOI: 10.1016/j.ijsu.2020.06.012 sha: f75138e872aa41adba4ad948ea9290f9e9e9f527 doc_id: 729338 cord_uid: owep0vsp nan As the COVID-19 pandemic shifted epicenters from Asia to Europe and the US, surgical societies issued guidelines urging deferment of elective procedures and advised nonoperative management of emergency conditions [1] . This was then deemed necessary as many healthcare systems were overwhelmed by the sheer scale of the pandemic and all resources were redirected towards tackling this. In addition, many were concerned about the possibility of viral transmission from affected or undiagnosed individuals to healthcare workers (HCW) and secondary nosocomial infection of other patients [2]. Today, as communities gradually relax lockdown measures and healthcare systems plan to reboot, the surgical community must anticipate a surge in both emergency and elective procedures. Cholecystectomy is one of the commonest abdominal surgeries performed worldwide. To date, there are several reports of COVID-19 patients undergoing cholecystectomy, including our institution's experience [3] [4] [5] [6] . Taking into account current available evidence, we provide some recommendations for performing cholecystectomy safely in suspected, presumed or confirmed COVID-19 patients. Thirdly, we recommend mandatory screening for all patients prior to surgery. It was previously suggested that a pre-operative chest X-ray and nasopharyngeal swab should be performed for all elective procedures. However, with better understanding that presymptomatic viral transmission can occur [12] and nasopharyngeal swab results may be negative in the initial phase of disease [4] , these measures alone may not be sufficient. In our institution, we call our patients 72 hours prior to surgery to ensure that they have no acute respiratory illness or recent travel history [2, 11] . A repeat declaration is made on the day of surgery. Any patient who is unwell, or has come into contact with COVID-19 positive patients, may have their procedures postponed. In the event that a suspected patient requires emergent cholecystectomy even before swab results are available, full precautionary measures are taken and enhanced personal protective equipment (PPE) is donned during surgery [2, 6, 8, 11, 12] . In conclusion, the battle against this pandemic will be long-drawn. However, we hope that the three components of the 'new' critical view of safety, namely a) knowledge that SARS-CoV-2-RNA is not present in bile, b) evidence of safe laparoscopic surgery in COVID-19 infected patients and c) implementation of rigorous pre-operative screening measures, will help to allay fears in surgeons who find themselves having to perform cholecystectomy during these unprecedented times. Singapore perspective Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19 An underestimated "false negative COVID cholecystitis" in Northern Italy and the contagion of a surgical ward: it can happen everywhere Hazardous Postoperative Outcomes of Unexpected COVID-19 Infected Patients: A Call for Global Consideration of Sampling all Asymptomatic Patients Before Surgical Treatment The Covid Conundrum: SARS-CoV-2 is not present in bile Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos) SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients COVID-19 not detected in peritoneal fluid: a case of laparoscopic appendicectomy for acute appendicitis in a COVID-19-infected patient ELSA recommendations for minimally invasive surgery during a community spread pandemic: a centered approach in Asia from widespread to recovery phases A call to arms: a perspective of safe general surgery in Singapore during the COVID-19 pandemic Safe Colorectal Surgery in the COVID-19 Era -A Singapore Experience The authors have no conflicts of interest to declare.The authors confirm that this manuscript has not been published elsewhere previously, and has not been submitted for publication elsewhere. The following additional information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories, then this should be stated. No funding was required for this study No ethical approval was required for this cohort correspondence. Our patient who underwent cholecystectomy gave approval for use of his information for this report, and we have a signed consent form in our institution. Please enter the name of the registry, the hyperlink to the registration and the unique identifying number of the study. You can register your research at http://www.researchregistry.com to obtain your UIN if you have not already registered your study. This is mandatory for human studies only.1. Name of the registry: NA 2. Unique Identifying number or registration ID: NA 3. Hyperlink to your specific registration (must be publicly accessible and will be checked): NA Please specify the contribution of each author to the paper, e.g. study design, data collections, data analysis, writing. Others, who have contributed in other ways should be listed as contributors.Study design: TK, CMH Data collection: TK Writing: TK, CMH Manuscript review: All authors The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish. Please note that providing a guarantor is compulsory. Cholecystectomy during the COVID-19 pandemic: current evidence and an The data that has been used confidential.